Fusco Nicholas M, Parbuoni Kristine A, Morgan Jill A
Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York.
Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, California.
J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):37-44. doi: 10.5863/1551-6776-20.1.37.
Delay of antimicrobial administration in adult patients with severe sepsis and septic shock has been associated with a decrease in survival to hospital discharge. The primary objective of this investigation was to determine the time to first antimicrobial administration after the onset of sepsis in critically ill children. Secondary objectives included appropriateness of empiric antimicrobials and microbiological testing, fluid resuscitation during the first 24 hours after onset of sepsis, intensive care unit and hospital length of stay, and mortality.
Retrospective, chart review of all subjects less than or equal to 18 years of age admitted to the pediatric intensive care unit (PICU) with a diagnosis of sepsis between January 1, 2011, and December 31, 2012.
A total of 72 subjects met the inclusion criteria during the study period. Median time to first antimicrobial administration by a nurse after the onset of sepsis was 2.7 (0.5-5.1) hours. Cultures were drawn prior to administration of antimicrobials in 91.7% of subjects and were repeated within 48 hours in 72.2% of subjects. Empiric antimicrobial regimens were appropriate in 91.7% of cases. The most common empiric antimicrobial regimens included piperacillin/tazobactam plus vancomycin in 19 subjects (26.4%) and ceftriaxone plus vancomycin in 15 subjects (20.8%). Median PICU length of stay was 129 (64.6-370.9) hours, approximately 5 days, and median hospital length of stay was 289 (162.5-597.1) hours, approximately 12 days. There were 4 deaths during the study period.
Time to first antimicrobial administration after onset of sepsis was not optimal and exceeded the recommendations set forth in international guidelines. At our institution, the process for treating pediatric patients with severe sepsis and septic shock should be modified to increase compliance with national guidelines.
成年严重脓毒症和脓毒性休克患者抗菌药物给药延迟与出院生存率降低相关。本研究的主要目的是确定危重症儿童脓毒症发作后首次给予抗菌药物的时间。次要目的包括经验性抗菌药物和微生物检测的合理性、脓毒症发作后最初24小时内的液体复苏、重症监护病房(ICU)住院时间和住院时间以及死亡率。
对2011年1月1日至2012年12月31日期间入住儿科重症监护病房(PICU)且诊断为脓毒症的所有18岁及以下受试者进行回顾性病历审查。
研究期间共有72名受试者符合纳入标准。脓毒症发作后护士首次给予抗菌药物的中位时间为2.7(0.5 - 5.1)小时。91.7%的受试者在给予抗菌药物前进行了培养,72.2%的受试者在48小时内重复进行了培养。91.7%的病例经验性抗菌治疗方案是合适的。最常见的经验性抗菌治疗方案包括19名受试者(26.4%)使用哌拉西林/他唑巴坦加万古霉素,15名受试者(20.8%)使用头孢曲松加万古霉素。PICU中位住院时间为129(64.6 - 37,0.9)小时,约5天,住院中位时间为289(162.5 - 597.1)小时,约12天。研究期间有4例死亡。
脓毒症发作后首次给予抗菌药物的时间不理想,超过了国际指南提出的建议。在我们机构,应修改治疗儿童严重脓毒症和脓毒性休克的流程,以提高对国家指南的依从性。